当囊胚达到相似优质质量时,第5天移植前是否需要考虑第2天和第3天胚胎形态?
该回顾性研究比较了2012年1月至2016年3月间291例第5天囊胚移植的临床结局,按第2天和第3天胚胎质量分组。第2天优质与劣质胚胎组的着床率、临床妊娠率、流产率和活产率相当;多变量分析显示第2天和第3天胚胎质量不能预测优质囊胚的着床。作者认为在预后良好人群中,无论卵裂期胚胎质量如何,均应进行优质囊胚移植。
要点
- 第2天优质与劣质胚胎组的着床率、临床妊娠率、流产率和活产率相当。
- 第2天和第3天胚胎质量均不能预测优质囊胚的着床。
- 作者认为在预后良好人群中,无论卵裂期胚胎质量如何,均应进行优质囊胚移植。
核心结论
- 在预后良好人群中,无论卵裂期胚胎质量如何,均应进行优质囊胚移植,因为这可能不会损害成功率。
研究设计与样本
- 回顾性比较2012年1月至2016年3月间291例第5天囊胚移植的临床结局,按第2天和第3天胚胎质量分组。
- 纳入标准为女性年龄小于37岁;首次或第二次体外受精和卵胞浆内单精子注射周期;移植囊胚质量:囊胚腔B3或更高;内细胞团A/B;滋养层A/B;且每个移植囊胚的着床结局已知。
主要发现
- 第2天优质与劣质胚胎组的着床率为38.7%对41.4%,临床妊娠率为40.3%对45.9%,流产率为22.2%对26.7%,活产率为37.4%对38.8%,两组相当。
- 第3天移植囊胚的形态学未发现显著差异。
- 多变量分析显示,第2天和第3天胚胎质量优劣均不能预测优质囊胚的着床(第2天:调整比值比=0.82,95%置信区间0.49至1.38;第3天:调整比值比=1.39;95%置信区间0.77至2.52)。
临床怎么用
- 作者认为,在预后良好人群中,无论卵裂期胚胎质量如何,均应进行优质囊胚移植。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical outcomes of 291 day-5 blastocyst transfers carried out between January 2012 and March 2016 were retrospectively compared according to their quality at day 2 and 3. Inclusion criteria were female age younger than 37 years; first or second IVF and intracytoplasmic sperm injection cycle; quality of the transferred blastocyst: blastocoele B3 or higher; inner-cell-mass A/B; trophectoderm A/B; and known implantation outcome for each transferred blastocyst. Blastocysts were classified into good-quality and poor-quality embryo groups at day 2 and 3. Implantation (38.7% versus 41.4), clinical pregnancy (40.3% versus 45.9%), miscarriage (22.2% versus 26.7%;) and live birth rates (37.4% versus 38.8%) were comparable in day 2 good and poor-quality embryo groups. No signficiant differences in morphology of transferred blastocysts at day 3 were found. Multivariable analysis highlighted that poor or good embryo quality at day 2 and day 3 were not predictive of the implantation of good-quality blastocysts (at day 2: adjusted odds ratio = 0.82 CI 95% 0.49 to 1.38; at day 3: adjusted odds ratio = 1.39; CI 95% 0.77 to 2.52). Good-quality blastocyst transfer should, therefore, be carried out irrespective of embryo quality at cleavage stage, as it may not compromise success rates in a good-prognosis population.
引用
- Herbemont C, Sarandi S, Boujenah J, et al. Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality? Reprod Biomed Online. 2017. PMID: 28887104. doi:10.1016/j.rbmo.2017.07.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。